Wireless Hemodynamic Pressure Monitoring Using CardioMEMS
ABSTRACT
Biosensors and remote monitoring of chronic diseases are part of a growing demand for home-based personalized medicine, a need further emphasized and accelerated by the COVID-19 pandemic. The leading cause of death in the world, cardiovascular disease, is a complex issue that includes Heart Failure (HF). This chronic condition affects over 6 million people in the US and over 64 million globally. With a 50% mortality rate in 5 years, HF costs the US over 30 billion dollars annually to manage. Historically, standard-of-care for HF management relied on worsening symptoms, weight gain/loss, and occasional measurement of cardiac pressures in the hospital using minimally invasive right heart catheterization (RHC) procedures. However, chronic disease management is less effective when key indicators are not monitored in the right environment and with the correct cadence. MEMS-based implantable wireless pressure sensors have revolutionized the management of HF, reduced hospitalizations, and improved quality of life. This talk will describe the CardioMEMSTM sensor technology, its use, and challenges related to cardiovascular implantable pressure sensors, a first step towards reducing heart failure progression and life extension.
BIOGRAPHY
Michael Fonseca has over 20 years of experience developing MEMS-based medical devices and currently serves as the Director of Product Development for Abbott’s Heart Failure division, focused on remote monitoring of chronic diseases.
Concurrent with earning his Ph.D. in EE from Georgia Tech, he joined the medical device startup world, where CardioMEMS, Inc. successfully commercialized the world’s first permanently implantable wireless MEMS pressure sensor for remote monitoring of chronic diseases. The startup commercialized wireless pressure sensing platforms to remotely monitor endovascular repair of aortic and thoracic aneurysms (AAA EndoSureTM) and chronic heart failure patients (CardioMEMSTM HF System).
Since 2017, he’s also served as adjunct faculty for Georgia Tech’s Master of Biomedical Innovation and Development (MBID), part of the Wallace H. Coulter Department of Biomedical Engineering.